Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas

Background N-myc (and STAT) interactor (NMI) plays vital roles in tumor growth, progression, and metastasis. In this study, we identified NMI as a potential tumor suppressor in lung cancer and explored its molecular mechanism involved in lung cancer progression.